BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18337725)

  • 1. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
    Rottbauer W; Gautel M; Zehelein J; Labeit S; Franz WM; Fischer C; Vollrath B; Mall G; Dietz R; Kübler W; Katus HA
    J Clin Invest; 1997 Jul; 100(2):475-82. PubMed ID: 9218526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency.
    Andersen PS; Havndrup O; Bundgaard H; Larsen LA; Vuust J; Pedersen AK; Kjeldsen K; Christiansen M
    Eur J Hum Genet; 2004 Aug; 12(8):673-7. PubMed ID: 15114369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
    Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac troponin I gene is not associated with hypertrophic cardiomyopathy in patients from eastern Finland.
    Jääskeläinen P; Miettinen R; Silvennoinen K; Vauhkonen I; Laakso M; Kuusisto J
    J Mol Cell Cardiol; 1999 Nov; 31(11):2031-6. PubMed ID: 10591029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Ederer MM; Hendrix KP; Kittleson MD
    Genomics; 2007 Aug; 90(2):261-4. PubMed ID: 17521870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
    Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.
    Coto E; Reguero JR; Palacín M; Gómez J; Alonso B; Iglesias S; Martín M; Tavira B; Díaz-Molina B; Morales C; Morís C; Rodríguez-Lambert JL; Corao AI; Díaz M; Alvarez V
    J Mol Diagn; 2012 Sep; 14(5):518-24. PubMed ID: 22765922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Family hypertrophic cardiomyopathy caused by a 14035c > t mutation in cardiac troponin T gene].
    Wang SX; Zou YB; Fu CY; Song L; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):371-4. PubMed ID: 17456375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.